Clinical Trial Update: A Study of Belimumab in Chinese Pediatric Participants With Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

Phase 1 study of belimumab in Chinese pediatric participants with systemic lupus erythematosus has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• BENLYSTA (belimumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: COMPLETED | Results posted: 2025-11-14